Document Detail


Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
MedLine Citation:
PMID:  21299439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: The positive results of pioneering clinical trials using gene therapy as treatment for patients with Leber congenital amaurosis (LCA) have ushered in a new era of molecular retinal therapeutics for LCA, other blinding retinal disorders and gene therapy applications.
AREAS COVERED: This review describes the role of retinal pigment epithelium-specific 65 kDa protein (RPE65) in the visual cycle and how RPE65 deficiency results in LCA; the extensive preclinical studies with recombinant adeno-associated virus (rAAV)-RPE65 gene vectors; and the human rAAV-RPE65 and related gene therapy clinical trials and studies. The literature search included a review of primary sources (e.g., journal articles) that reported study data results and key secondary sources such as meta-reviews available through PubMed, as well as reviews of clinical trial descriptions and results as reported in clinicaltrials.gov, conference publications and news releases.
EXPERT OPINION: LCA-RPE65 gene therapy is an example of successful, innovative, translational research. Further research is needed regarding how retinal gene therapy can be improved.
Authors:
Linda Stein; Kamolika Roy; Lei Lei; Shalesh Kaushal
Related Documents :
16376029 - Comparative genome analyses of nervous system-specific genes.
19426549 - Insights into the evolution of the snail superfamily from metazoan wide molecular phylo...
20141639 - Homeolog loss and expression changes in natural populations of the recently and repeate...
10597639 - Gene function, gene networks and the fate of duplicated genes.
21541659 - Integration of gene chip and topological network techniques to screen a candidate bioma...
17805289 - Natural history and evolutionary principles of gene duplication in fungi.
14500789 - Down-regulating alpha-galactosidase enhances freezing tolerance in transgenic petunia.
21357679 - Growth arrest-specific 1 binds to and controls the maturation and processing of the amy...
23252959 - Qualitative and quantitative expression status of the human chromosome 20 genes in canc...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on biological therapy     Volume:  11     ISSN:  1744-7682     ISO Abbreviation:  Expert Opin Biol Ther     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-08     Completed Date:  2011-05-23     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  101125414     Medline TA:  Expert Opin Biol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  429-39     Citation Subset:  IM    
Affiliation:
University of Massachusetts Medical School, UMass Memorial Eye Center, Department of Ophthalmology, 281 Lincoln St., Worcester, MA 01605, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carrier Proteins / genetics*,  metabolism
Dependovirus / genetics
Evidence-Based Medicine
Eye Proteins / genetics*,  metabolism
Gene Transfer Techniques
Genetic Therapy* / adverse effects
Genetic Vectors
Humans
Leber Congenital Amaurosis / genetics,  metabolism,  physiopathology,  therapy*
Retina / metabolism*,  physiopathology
Translational Medical Research
Treatment Outcome
Vision, Ocular
cis-trans-Isomerases
Chemical
Reg. No./Substance:
0/Carrier Proteins; 0/Eye Proteins; EC 3.1.1.64/retinoid isomerohydrolase; EC 5.2.-/cis-trans-Isomerases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement.
Next Document:  Mitral deceleration index is associated with aortic root dilatation and not to biventricular structu...